 The new legislation would have made it "virtually impossible" for the DEA to stop these sales, according to internal agency documents, Justice Department documents, and the DEA Chief Administrative Law Judge John J. Mulrooney II.Marino, whose district was heavily affected by the opioid epidemic, declined to comment on the reports.The drug industry spent at least $102 million lobbying Congress on the legislation between 2014 and 2016.